Cholangiocarcinoma Clinical Trials in Toronto, Ontario
3 recruitingToronto, Ontario, Canada
Showing 1–3 of 3 trials
Recruiting
Phase 1Phase 2
A Study of an FGFR2/3 Inhibitor (CGT4859) in Patients With Cholangiocarcinoma and Other Advanced Solid Tumors
CholangiocarcinomaAdvanced Solid TumorsIntrahepatic Cholangiocarcinoma (Icc)+9 more
Cogent Biosciences, Inc.110 enrolled15 locationsNCT06777316
Recruiting
Not Applicable
The Dragon PLC Trial (DRAGON-PLC)
CholangiocarcinomaHepatocellular Carcinoma (HCC)Primary Liver Cancer
Maastricht University358 enrolled55 locationsNCT06914648
Recruiting
Phase 2
Study of Olaparib and Durvalumab in IDH-Mutated Solid Tumors
CholangiocarcinomaSolid TumorGlioma+1 more
University Health Network, Toronto58 enrolled1 locationNCT03991832